Citadel Advisors’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $149K | Buy |
|
|||||
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $713K | Sell |
|
|||||
|
2025
Q1 | $1.07M | Sell |
|
|||||
|
2024
Q4 | $3.37M | Buy |
|
|||||
|
2024
Q3 | $1.38M | Buy |
|
|||||
|
2024
Q2 | $1.54M | Sell |
|
|||||
|
2024
Q1 | $2.81M | Buy |
|
|||||
|
2023
Q4 | $376K | Sell |
|
|||||
|
2023
Q3 | $1.82M | Buy |
|
|||||
|
2023
Q2 | $341K | Buy |
|
|||||
|
2023
Q1 | $83.8K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $984K | Sell |
|
|||||
|
2022
Q2 | $1.57M | Buy |
|
|||||
|
2022
Q1 | $733K | Buy |
|
|||||
|
2021
Q4 | $700K | Buy |
|
|||||
|
2021
Q3 | $373K | Sell |
|
|||||
|
2021
Q2 | $658K | Buy |
|
|||||
|
2021
Q1 | $851K | Sell |
|
|||||
|
2020
Q4 | $2.17M | Buy |
|